skip to Main Content
 

Cell and Gene Therapy in Oncology, Part III

  • This page as PDF

Summary

Tune into another episode of the Avalere Health Essential Voice podcast series focused on disease education. In this segment, the final in our series on cell and gene therapies, experts from our Market Access practice discuss the need for patient support in cell and gene therapies, and the role that manufacturers and other stakeholders can play in providing it.
“Leveraging real-world claims data and socioeconomic status data to help understand the patient population will be a benefit for manufacturers as they're looking to build out additional support services to ensure that they're reaching patients in an adequate manner.” Michael Kearney

Panelists

Moderator
Amelia Nell , Senior Associate, Policy

Amelia Nell supports clients with evidence-based research and analysis that spans healthcare sectors and stakeholders.

Speaker
Brigit Kyei-Baffour , Associate Principal, Market Access & Reimbursement

Brigit Kyei-Baffour advises clients on issues related to reimbursement, policy, and market access strategies for diagnostic, medical device, and pharmaceutical companies.

Speaker
Michael Kearney , Consultant II, Market Access & Reimbursement

Michael provides strategic guidance and analytic support for providers across the continuum of care, from physician groups to hospitals and health systems and post-acute care organizations.

If you would like to watch the video version, please visit our video page.

From beginning to end, our team synergy
produces measurable results. Let's work together.

Sign up to receive more insights about Value-Based Care
Please enter your email address to be notified when new Value-Based Care insights are published.

Back To Top